# Investigating-Potential-EGFR-Kinase-Inhibitors-for-Lung-Cancer-Treatment
Used SwissDock, a computational biology web service, to predict protein-ligand docking and evaluate potential EGFR tyrosine kinase inhibitors that can be used to treat non-small-cell lung cancer
